99 related articles for article (PubMed ID: 10569135)
1. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G
Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
[No Abstract] [Full Text] [Related]
2. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Carbone A; Gaidano G; Gloghini A; Larocca LM; Capello D; Canzonieri V; Antinori A; Tirelli U; Falini B; Dalla-Favera R
Blood; 1998 Feb; 91(3):747-55. PubMed ID: 9446632
[TBL] [Abstract][Full Text] [Related]
4. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL
Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders.
Abed N; Casper JT; Camitta BM; Margolis D; Trost B; Orentas R; Chang CC
Bone Marrow Transplant; 2004 Feb; 33(3):321-7. PubMed ID: 14688820
[TBL] [Abstract][Full Text] [Related]
8. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
9. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders.
Paessler M; Kossev P; Tsai D; Raghunath P; Majewski M; Zhang Q; Ramalingam P; Schuster S; Tomaszewski J; Arber DA; Hsi E; Wasik MA
Lab Invest; 2002 Nov; 82(11):1599-606. PubMed ID: 12429820
[TBL] [Abstract][Full Text] [Related]
10. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
[TBL] [Abstract][Full Text] [Related]
11. SYNDECAN-1 (CD138) expression in human non-Hodgkin's lymphomas.
Sutcliffe M; Oscier D; Wright DH
Br J Haematol; 2000 Jul; 110(1):239-40. PubMed ID: 10931010
[No Abstract] [Full Text] [Related]
12. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
[TBL] [Abstract][Full Text] [Related]
13. Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells?
Carbone A; Gloghini A; Gaidano G
Adv Clin Path; 1999; 3(1-2):3-9. PubMed ID: 10655568
[TBL] [Abstract][Full Text] [Related]
14. Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses.
Brighenti A; Andrulis M; Geissinger E; Roth S; Müller-Hermelink HK; Rüdiger T
Histopathology; 2005 Jul; 47(1):90-100. PubMed ID: 15982328
[TBL] [Abstract][Full Text] [Related]
15. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
16. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
Natkunam Y; Warnke RA; Montgomery K; Falini B; van De Rijn M
Mod Pathol; 2001 Jul; 14(7):686-94. PubMed ID: 11455001
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
Kraus MD; Haley J
Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
[TBL] [Abstract][Full Text] [Related]
19. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
[TBL] [Abstract][Full Text] [Related]
20. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
